PHA-Exchange> Fw: News Pharmabiz -Ban of nimesulide for pediatric use

[jo]

----- Original Message ----- 
From: R.Sweety Prem Kumar 
To: Sujith Chandy ; Santhanu K. Tripathi ; shailendra awale ;  jvarghese at cmai.org 
Sent: Saturday, February 22, 2003 6:56 PM
Subject: News published in Pharmabiz


Govt of India not keen to ban nimesulide for pediatric use
                    Friday, February 21, 2003 08:00 IST 
                    Our Bureau, New Delhi

                    The Government of India is in no mood to ban the use of
                    nimesulide for pediatric purpose in the country. In a written
                    reply to a question by Ramanaidu Duggubati in Lok Sabha on
                    February 18, 2003, Dr. Chhattra Pal Singh, Minister of State for
                    Chemicals and Fertilizers stated that majority of the experts
                    within the country have confirmed the reliability and safety of
                    the drug. 

                    He informed that a detailed examination has been undertaken
                    by an Expert Committee (Sub-Committee) of Drug Technical
                    Advisory Board to deliberate on the issues concerning the
                    safety of nimesulide, including its use in children. "More than 20
                    expert paediatricians across the country and the Indian
                    Academy of Paediatrics (IAP) were consulted. Majority of
                    experts have confirmed the reliability of nimesulide and no
                    serious adverse reaction in children have been reported in the
                    country," he stated. 

                    The minister also explained that the drug has not been banned
                    in almost all countries. The use of nimesulide is reported to
                    have been suspended only in Spain, Turkey and Finland.
                    Nimisulide, a non-steroidal anti-inflammatory drug (NSAID), is
                    reported to be used in about 50 countries including India and is
                    indicated for acute pain/inflammation and fever. In India, the
                    drug was approved in 1995, and it is a prescription drug, he
                    informed. 
 
 
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://phm.phmovement.org/pipermail/phm-exchange-phmovement.org/attachments/20030227/a2ace898/attachment-0001.html>